J&T Global Express Ltd
F:J92
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J&T Global Express Ltd
F:J92
|
CN |
|
V
|
Vibhavadi Medical Center PCL
SET:VIBHA
|
TH |
|
ArcBest Corp
NASDAQ:ARCB
|
US |
|
Cooper-Standard Holdings Inc
NYSE:CPS
|
US |
|
Medtronic PLC
NYSE:MDT
|
IE |
|
DIP Corp
TSE:2379
|
JP |
|
Brinks Co
NYSE:BCO
|
US |
|
Chemed Corp
NYSE:CHE
|
US |
|
Cigna Corp
NYSE:CI
|
US |
|
Pernod Ricard SA
PAR:RI
|
FR |
Wall St Price Targets
J92 Price Targets Summary
J&T Global Express Ltd
According to Wall Street analysts, the average 1-year price target for J92 is 1.43 EUR with a low forecast of 0.81 EUR and a high forecast of 1.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is J92's stock price target?
Price Target
1.43
EUR
According to Wall Street analysts, the average 1-year price target for J92 is 1.43 EUR with a low forecast of 0.81 EUR and a high forecast of 1.71 EUR.
What is the Revenue forecast for J&T Global Express Ltd?
Projected CAGR
22%
Over the last 4 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 4 years is 22%.
What is the Operating Income forecast for J&T Global Express Ltd?
Projected CAGR
46%
The compound annual growth rate for Operating Income over the next 4 years is 46%.
What is the Net Income forecast for J&T Global Express Ltd?
Projected CAGR
72%
The compound annual growth rate for Net Income over the next 4 years is 72%.
